Insigneo Advisory Services’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Insigneo Advisory Services's REGN Position: Q2 2026 in Review
Insigneo Advisory Services increased its Regeneron Pharmaceuticals (REGN) stake by 70% in Q2 2026, buying an estimated $208K and bringing the position to 742 shares worth $463K. The position accounts for 0.02% of the portfolio, ranked #503.
Insigneo Advisory Services first reported a position in REGN in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.13M in Q2 2024. 1,340 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Insigneo Advisory Services held 742 shares of Regeneron Pharmaceuticals worth $463K as of Q2 2026.
- Insigneo Advisory Services bought 305 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $208K.
- Regeneron Pharmaceuticals made up 0.02% of Insigneo Advisory Services's portfolio in Q2 2026, its #503 holding.
- Insigneo Advisory Services first reported a position in Regeneron Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
- Insigneo Advisory Services's Regeneron Pharmaceuticals position peaked at $1.13M in Q2 2024.
- 1,340 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Insigneo Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.